{"Symbol": "ADVB", "AssetType": "Common Stock", "Name": "Advanced Biomed Inc. Common Stock", "Description": "Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. The company is headquartered in New York, New York.", "CIK": "1941029", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DIAGNOSTICS & RESEARCH", "Address": "122 EAST 42ND STREET, NEW YORK, NY, UNITED STATES, 10168", "OfficialSite": "https://www.advanbiomed.com", "FiscalYearEnd": "June", "LatestQuarter": "2025-12-31", "MarketCapitalization": "6552500", "EBITDA": "-2971404", "PERatio": "None", "PEGRatio": "None", "BookValue": "0.438", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.17", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.269", "ReturnOnEquityTTM": "0.802", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-0.17", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "2.226", "EVToRevenue": "-", "EVToEBITDA": "-", "Beta": "None", "52WeekHigh": "4.1", "52WeekLow": "0.211", "50DayMovingAverage": "0.327", "200DayMovingAverage": "0.576", "SharesOutstanding": "27290700", "SharesFloat": "7376900", "PercentInsiders": "77.230", "PercentInstitutions": "0.979", "DividendDate": "None", "ExDividendDate": "None"}